| 发明名称 |
Combination Therapy For B Cell Lymphomas |
| 摘要 |
The present disclosure provides methods for treating B cell lymphomas using a combination of anti-CD19 and anti-CD20 antibodies. Such methods provide therapeutic advantages over single antibody therapies, including prolonged anti-tumor activity and/or reduced dosages. |
| 申请公布号 |
US2013330328(A1) |
申请公布日期 |
2013.12.12 |
| 申请号 |
US201113885219 |
申请日期 |
2011.11.14 |
| 申请人 |
HERBST RONALD;WARD ELIZABETH K.;MCKEEVER KATHLEEN PHILLIPS;MEDIMMUNE, LLC |
发明人 |
HERBST RONALD;WARD ELIZABETH K.;MCKEEVER KATHLEEN PHILLIPS |
| 分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
